Fuel Energy at the Cellular Level and Strengthen Mitochondrial Health
Growing interest in mitochondrial health and cellular energy, together with increasing demand for energy solutions, is driving strong growth in the cellular-level supplement market.
Global searches for “mitochondrial health” grew 10-fold in 2025, according to Google Trends.1
Rising awareness of mitochondrial health and cellular energy production is expected to drive the “cellular nutrition market” to $1.35 billion by 2035, at a 7.2% CAGR.3
XtraMyo™ enhances skeletal muscle energy metabolism through dual mechanisms: upregulating mitochondrial succinate dehydrogenase (SDH) activity in the inner mitochondrial membrane and increasing intramuscular glycogen storage, a key energy reserve for sustained activity.
This combined effect improves mitochondrial efficiency and leads to increased ATP production.
Succinate dehydrogenase (SDH) is a key mitochondrial enzyme for energy production, located in the inner mitochondrial membrane. Its activity is essential for efficient cellular energy generation.
XtraMyo™ supplementation significantly increased muscle mitochondrial SDH activity to almost threefold in aged mice after 8 weeks, indicating enhanced mitochondrial ATP production efficiency.
Muscle glycogen is a critical energy reserve, serving as a primary fuel source during physical activity and supporting sustained energy availability. Adequate glycogen storage is essential for optimal muscle strength and endurance.
XtraMyo™ supplementation significantly increased muscle glycogen storage to twofold in aged mice after 8 weeks, indicating an expanded cellular energy storage capacity in muscle tissue.
The global sports supplements market is projected to reach a substantial USD 189.38 billion by 2033, growing at a CAGR of 8.7%.
Grip strength is a widely used indicator of overall muscle strength and functional capacity.
XtraMyo™ supplementation enhanced grip strength by 20% at 2.5B and by 30% at 5B in aged mice after 8 weeks, indicating improved muscle strength and performance.
The recommended dose of XtraMyo™ for a healthy adult is one unit daily according to specific requirements.
Benefits of XtraMyo™ for Mitochondrial Health and Cellular Energy:
Your Target Audience Who Are
Market-Ready Formula Concepts
The Scientifically Proven, Market-Ready Solution to Set Your Products Apart and
Accelerate Your Success
XtraMyo™ PRODUCT CONCEPTS
Ingredient:
Vigiis 101-LAB
Application:
Supports Healthy Blood Lipid Levels*
Promotes Healthy Cholesterol Levels Already Within Normal Range*
Supports Cardiovascular Health*
The communication is intended for business-to-business information and not for the final consumer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.